News & Analysis on Clinical Trial Services & Contract Research And Development
Roche has entered into an agreement to provide drug compounds for cardiotoxicity testing using a cell-based platform that could play a major role in the preclinical safety evaluation of drugs and newly developed compounds.
Drug delivery specialist Eurand could see a marked increase in revenue flow this year, both from co-development products incorporating the company's formulation technologies and a proprietary treatment addressing the estimated $720m worldwide market...
DNA sequencing services provider GATC Biotech has announced the opening of a new subsidiary in Stockholm, Sweden, as it widens the net in Europe.
The made-in-China heparin scare has now spread beyond the US, with Germany and Japan both recalling the drug.
The prospects for a viable market in inhaled insulin therapies were looking markedly thinner this week after Eli Lilly pulled the plug on its joint development programme with drug delivery specialist Alkermes for AIR Insulin.
The CEO of Californian company Nektar Therapeutics says that 2007 has been key in transforming the company into a fully integrated drug development organisation, despite the setback with Pfizer's inhaled insulin product Exubera.